The programme is led by Professor Phil Beales Chair of the UCL Institute of Precision Medicine,
Professor of Medical and Molecular Genetics at the UCL Great Ormond Street Institute of Child Health and UCLPartners. The delivery of precision medicine requires several sectors (academia, healthcare and industry) work together. It is our mission to facilitate new and innovative collaborations with academia, industry and healthcare through the creation of the P4 programme.
UCL have partnered with Capital Enterprise, a body of connectors, influencers, investors and policy-makers, collaborating to serve and super-charge London’s start-up scene.
The P4 programme creates a new and unique ecosystem to facilitate the scale and adoption of precision medicine SMEs by providing access to unparalleled expertise in genomic profiling, drug targeting, disease marker discovery, diagnostics/companion diagnostics, clinical trials design and delivery, software development, engineering, artificial intelligence, regulatory compliance and health data. Cross-faculty support led by the UCL Institute for Precision Medicine, leverages the talent pool of academics at UCL and its partners. Capital Enterprise has experience of supporting and scaling tech SMEs and providing access to unique funding streams to ensure SMEs thrive.